Karyopharm Therapeutics KPTI
NASDAQ KPTI
$0.52 -0.03 (-5.45%)
At close: Oct 23, 2026 · 4:00 PM EDT

Karyopharm Therapeutics (KPTI) Cash & Current Investments (2012 - 2026)

Updated

Karyopharm Therapeutics (KPTI) posted Cash & Current Investments of $65.11 million for Q2 2026, up 25.9% from $51.7 million a year earlier.

Analysis

Karyopharm Therapeutics (KPTI) Cash & Current Investments (2012 - 2026) Analysis & Trends

At the end of FY2025, Karyopharm Therapeutics' Cash & Current Investments came in at $63.74 million, down 41.4% from FY2024.

  • Annual Cash & Current Investments has declined for three consecutive years, with a five-year compound annual growth rate of -23.9% (FY2020 to FY2025).
  • In prior years, Karyopharm Therapeutics' Cash & Current Investments was $108.71 million in FY2024 (-43.2%), $191.44 million in FY2023 (-31.1%), $277.97 million in FY2022 (+21.6%) and $228.62 million in FY2021 (-8.3%).
  • The Q2 2026 figure stands as the highest quarterly Cash & Current Investments since Q1 2025.
  • On a year-over-year basis, Cash & Current Investments increased in 1 of the last seven quarters, with an average decline of 39.9%.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2023, with growth of 40.4%; the weakest was Q2 2025, with a decline of 66.0%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 17.23 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 6.57 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 11.70 Bn
10 Karyopharm Therapeutics 15.05 Mn -211.38 Mn 32.35 Mn 65.11 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 65.11 Mn
Dec 31, 2025 63.74 Mn
Sep 30, 2025 45.88 Mn
Jun 30, 2025 51.70 Mn
Mar 31, 2025 69.94 Mn
Dec 31, 2024 108.71 Mn
Sep 30, 2024 133.53 Mn
Jun 30, 2024 152.12 Mn
Mar 31, 2024 148.58 Mn
Dec 31, 2023 191.44 Mn
Sep 30, 2023 208.32 Mn
Jun 30, 2023 236.77 Mn
Mar 31, 2023 260.38 Mn
Dec 31, 2022 277.97 Mn
Sep 30, 2022 148.38 Mn
Jun 30, 2022 170.85 Mn
Mar 31, 2022 205.31 Mn
Dec 31, 2021 228.62 Mn
Sep 30, 2021 204.21 Mn
Jun 30, 2021 235.89 Mn
API Access

Karyopharm Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=KPTI&period=max&api_key=YOUR_API_KEY